School of Medicine and Health Sciences

Vafa Suleymanova

Vafa Suleymanova

Additional position
Nephrologist, Lecturer

Background

Vafa Suleymanova - is a physician and nephrology specialist, currently serving as a lecturer at the School of Medicine and Health Sciences of Qarabağ University.

She completed her medical education at the Azerbaijan Medical University, Faculty of Medicine, between 2009 and 2015. She subsequently pursued her residency in Internal Medicine at Istanbul University Faculty of Medicine from 2017 to 2021, followed by subspecialty training in Nephrology at the same institution from 2022 to 2025.

Between 2021 and 2022, she worked as an Internal Medicine specialist at Memorial Bahçelievler Hospital.

Her academic interests include chronic kidney disease, glomerulonephritis, kidney transplantation, hemodialysis, and peritoneal dialysis. She is also actively engaged in enhancing the integration of theoretical knowledge with clinical practice and supporting the development of students’ clinical reasoning skills.

Degrees

Azerbaijan Medical University, Faculty of Medicine, Baku — Medical Education (MD), (2009–2015)
Istanbul University, Faculty of Medicine, Istanbul — Residency in Internal Medicine, (2017–2021)
Istanbul University, Faculty of Medicine, Istanbul — Fellowship in Nephrology, (2022–2025)

Research Interests

Glomerulonephritis - Investigation of the immunopathogenesis, histopathological characteristics, and clinical-prognostic factors of primary and secondary glomerulonephritis; evaluation of disease activity and chronicity indices; optimization of personalized immunosuppressive treatment strategies.

Kidney Transplantation - Pathophysiology of early and late post-transplant complications; clinical-pathological characteristics of recurrent and de novo glomerular diseases; biomarkers of allograft dysfunction; evaluation of the efficacy and safety balance of immunosuppressive therapy.

Acute and Chronic Kidney Failure - Etiology and prognostic determinants of acute kidney injury (AKI); mechanisms of progression in chronic kidney disease (CKD), including cardiorenal and metabolic interactions; improvement of early diagnosis and risk stratification models.

We use cookies in the delivery of our services. To learn about the cookies we use and information about your preferences and opt-out choices, please click here. By using our platform you agree to our use of cookies.